A Tracheal Aspirate-derived Airway Basal Cell Model Reveals a Proinflammatory Epithelial Defect in Congenital Diaphragmatic Hernia
- 1 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (9) , 1214-1226
Abstract
Rationale: Congenital diaphragmatic hernia (CDH) is characterized by incomplete closure of the diaphragm and lung hypoplasia. The pathophysiology of lung defects in CDH is poorly understood. Objectives: To establish a translational model of human airway epithelium in CDH for pathogenic investigation and therapeutic testing. Methods: We developed a robust methodology of epithelial progenitor derivation from tracheal aspirates of newborns. Basal stem cells (BSCs) from patients with CDH and preterm and term non-CDH control subjects were derived and analyzed by bulk RNA sequencing, assay for transposase accessible chromatin with sequencing, and air–liquid interface differentiation. Lung sections from fetal human CDH samples and the nitrofen rat model of CDH were subjected to histological assessment of epithelial defects. Therapeutics to restore epithelial differentiation were evaluated in human epithelial cell culture and the nitrofen rat model of CDH. Measurements and Main Results: Transcriptomic and epigenetic profiling of CDH and control BSCs reveals a proinflammatory signature that is manifested by hyperactive nuclear factor kappa B and independent of severity and hernia size. In addition, CDH BSCs exhibit defective epithelial differentiation in vitro that recapitulates epithelial phenotypes found in fetal human CDH lung samples and fetal tracheas of the nitrofen rat model of CDH. Furthermore, blockade of nuclear factor kappa B hyperactivity normalizes epithelial differentiation phenotypes of human CDH BSCs in vitro and in nitrofen rat tracheas in vivo. Conclusions: Our findings have identified an underlying proinflammatory signature and BSC differentiation defects as a potential therapeutic target for airway epithelial defects in CDH.Keywords
All Related Versions
Funding Information
- NIH (NICHD 2PO1HD068250)
- NIH (R21AI156597)
- NIH (NICHD 2PO1HD068250)
- NIH (R21AI156597)
This publication has 57 references indexed in Scilit:
- NF-κB Activation Limits Airway Branching through Inhibition of Sp1-Mediated Fibroblast Growth Factor-10 ExpressionThe Journal of Immunology, 2010
- Preparing for the First Breath: Genetic and Cellular Mechanisms in Lung DevelopmentDevelopmental Cell, 2010
- Basal cells as stem cells of the mouse trachea and human airway epitheliumProceedings of the National Academy of Sciences, 2009
- The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, EpitheliumCell Stem Cell, 2009
- Gata4 Is Necessary for Normal Pulmonary Lobar DevelopmentAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Mutations in STRA6 Cause a Broad Spectrum of Malformations Including Anophthalmia, Congenital Heart Defects, Diaphragmatic Hernia, Alveolar Capillary Dysplasia, Lung Hypoplasia, and Mental RetardationThe American Journal of Human Genetics, 2007
- Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defectsDevelopmental Biology, 2007
- Corticosteroids for fetuses with congenital diaphragmatic hernia: can we show benefit?Journal of Pediatric Surgery, 2006
- Prenatal glucocorticoids improve pulmonary morphometrics in fetal sheep with congenital diaphragmatic herniaJournal of Pediatric Surgery, 1997
- Nitrofen-induced diaphragmatic hernias in rats: An animal modelJournal of Pediatric Surgery, 1990